A focus on fast-acting & natural pain relief
3rd Oct, 2022

This post is specifically for health practitioners. Create a free account

Alternatively, view general public info.

Learn more about vital.ly

 

 

Inflammatory pain is a prominent health burden that impacts the lives of countless individuals. While acute pain serves as an important protective mechanism, at times it can be difficult to control, even with the use of acetaminophen and nonsteroidal anti-inflammatories (NSAIDs ) (1). Even more concerning, single doses of acetaminophen beyond 1,000 mg or ibuprofen over 400 mg can lead to adverse effects , which may cause patients to feel uncertain about conventional analgesics. Providing a safe and fast-acting approach, Rhuleave-K™ contains natural ingredients, curcumin and Boswellia serrata (boswellia). This clinically proven combination has been shown to help alleviate pain within 63 minutes (2), with similar time-to-effect as 1,000 mg of acetaminophen (3). Therefore, Rhuleave-K™ offers a natural approach to inflammatory pain.

 

Rhuleave-K™: full-spectrum analgesia

Curcumin and boswellia within Rhuleave-K™ have been shown to be as effective as over-the-counter (OTC) pain relief, including NSAIDs  (4) and acetaminophen (3). Underpinning the clinical efficacy of these plant extracts are a broad spectrum of anti-inflammatory mechanisms that target several stages of inflammation (5). Most notably, this combination inhibits proinflammatory enzymes, cyclooxygenase-2 (COX-2) (6) and lipoxygenase-5 (LOX-5) (7), which synthesize prostaglandins and leukotrienes that promote heat, swelling, redness, and pain (8). As such, by reducing the production of these mediators, curcumin and boswellia in Rhuleave-K™ can help relieve inflammatory pain. Moreover, through its dual actions on COX and LOX pathways, this therapeutic blend offers broader anti-inflammatory actions compared to NSAIDs  (7). However, unlike these mainstream anti-inflammatories, natural agents within Rhuleave-K™ are less likely to cause negative side effects (4).

 

Enhanced herbal absorption with SpeedTech™

Unique to the manufacture of Rhuleave-K™, proprietary SpeedTech technology enhances curcumin and boswellia absorption, helping to offset the low bioavailability of these extracts (9,10). By combining natural ingredients through a high-speed milling process, SpeedTech micronises botanical particles within a phospholipid-rich  base of sesame seed oil (11) to create a highly bioavailable dispersion of active compounds. For this reason, specialised SpeedTech technology can maximise the anti-inflammatory benefits of curcumin and boswellia extracts in Rhuleave-K™ for greater clinical effects.

 

Clinically studied benefits

Human clinical trial data indicates that a single dose of Rhuleave-K™ is as effective as 1,000 mg of acetaminophen for the relief of acute musculoskeletal pain (p<0.001) (3). In a randomised open-label study, healthy subjects (mean age 42) with grade 1 musculoskeletal strain  received either 1,000 mg/d Rhuleave-K™ (n=44) or 1,000 mg/d of acetaminophen (n=44) for seven days. Outcomes showed Rhuleave-K™ administration led to substantial pain relief within 2.5 hours (Figure 1), while after six hours, Rhuleave-K™ reduced total pain by 53.1%, which was comparable to acetaminophen use (55.4%). Moreover, after seven days, natural treatment was observed to improve pain quality and intensity by 71.8%, which mirrored OTC efficacy (73.6% improvement).

 

Figure 1. Pain reduction with Rhuleave-K™ is comparable to 1,000 mg of acetaminophen (3)

Inflagesic Fig 1

In addition, the fast-acting benefits of Rhuleave-K™ have been documented in 232 healthy individuals (mean age 36.4 years) with exercise-induced muscle pain (2). In this randomised double-blind placebo-controlled study, treatment reduced pain severity from > 74% to < 3% (p < 0.001), while no significant relief occurred in the placebo group. Notably, perceived pain relief occurred around 63 minutes, while complete pain relief was achieved in 3.1 hours. As such, these studies support the anti-inflammatory and analgesic effects of Rhuleave-K™.

 

Natural medicines achieving rapid and reliable pain relief

Delivering a proven solution for pain sufferers, curcumin and boswellia extracts within Rhuleave-K™ offer a natural alternative to conventional analgesia. This combination blends scientific SpeedTech methods with researched botanicals to prevent acute pain from holding patients back. As such, by prescribing anti-inflammatory herbal medicines within holistic treatments, practitioners can achieve even better results, allowing patients the freedom to live life to the fullest.

Loading...
References
1Kellstein D et al. Evaluation of fixed-dose combinations of ibuprofen and acetaminophen in the treatment of postsurgical dental pain: a pilot, dose-ranging, randomized study. Drugs in R&D. 2020;20(3):237-247.
2Murthy M et al. Fast relief of acute musculoskeletal pain in different body parts following exercise-a randomized double-blind placebo-controlled human study with Curcuma longa and Boswellia serrata extracts. Sch J App Med Sci. 2022;3:311-326.
3Rudrappa GH et al. Efficacy of high-dissolution turmeric-sesame formulation for pain relief in adult subjects with acute musculoskeletal pain compared to acetaminophen. Medicine. 2020;99(28):e20373.
4Bannuru RR et al. Efficacy of curcumin and Boswellia for knee osteoarthritis: systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(3):416-429.
5Peng Y et al. Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures. Drug Des Devel Ther. 2021;15:4503-4525.
6Bishnoi M et al. Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid. Indian J Exp Biol. 2006;44(2):128-132.
7Rao CV. Regulation of COX and LOX by curcumin. Adv Exp Med Biol. 2007;595:213-226.
8Martel-Pelletier J et al. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 2003;62(6):501-509.
9Schiborr C et al. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res. 2014;58(3):516-527.
10Meins J et al. Enhanced absorption of boswellic acids by a micellar solubilized delivery form of Boswellia extract. NFS Journal. 2018;11:12-16.
11Bali S et al. Ayurvedic lipid based rasayans - A perspective on the preparation and pharmacological significance of lipids on the bioavailability of phytoconstituents. J Ayurveda Integr Med. 2021;13(2):100526.